Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
CC transcript
Appointed director

HALOZYME THERAPEUTICS, INC. (HALO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 4 LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 1,925 shares @ $42.407, valued at $81.6k
Sold 8,075 shares @ $42.407, valued at $342.4k
Exercised 1,925 options to buy @ $18.41, valued at $35.4k
Exercised 8,075 options to buy @ $19.98, valued at $161.3k
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2023 4 Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $43.711, valued at $437.1k
Sold 10,000 shares @ $43.741, valued at $437.4k
07/27/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $42.796, valued at $428k
Sold 10,000 shares @ $42.689, valued at $426.9k
Sold 10,000 shares @ $43.79, valued at $437.9k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
Exercised 10,000 options to buy @ $13.87, valued at $138.7k
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/09/2023 4 Posard Matthew L. (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
05/09/2023 4 Miyashita Akiko Moni (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
05/09/2023 4 MATSUI CONNIE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
05/09/2023 4 Henderson Jeffrey William (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
05/09/2023 4 Duncan Barbara Gayle (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
05/09/2023 4 Daly James M (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
05/09/2023 4 Connaughton Bernadette (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
05/09/2023 4 BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 8,065 shares @ $0
Granted 11,371 options to buy @ $31, valued at $352.5k
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/09/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $45.469, valued at $454.7k
Sold 10,000 shares @ $43.259, valued at $432.6k
Sold 10,000 shares @ $42.727, valued at $427.3k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
03/01/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Gifted 10,000 shares @ $0
03/01/2023 4 Henderson Jeffrey William (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $48.51, valued at $485.1k
Sold 10,000 shares @ $47.71, valued at $477.1k
02/28/2023 4 LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 7,016 shares @ $49.548, valued at $347.6k
Sold 2,984 shares @ $49.549, valued at $147.9k
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2023 4 LaBarre Michael J. (SVP, CHIEF TECHNICAL OFFICER) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 2,951 shares @ $48.92, valued at $144.4k
Paid exercise price by delivering 2,725 shares @ $48.92, valued at $133.3k
Exercised 8,133 restricted stock units @ $0
Exercised 7,883 restricted stock units @ $0
02/14/2023 4 LaBrosse Nicole (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 1,392 shares @ $48.92, valued at $68.1k
Paid exercise price by delivering 681 shares @ $48.92, valued at $33.3k
Exercised 2,503 restricted stock units @ $0
Exercised 1,389 restricted stock units @ $0
02/14/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 16,469 shares @ $48.92, valued at $805.7k
Paid exercise price by delivering 17,266 shares @ $48.92, valued at $844.7k
Exercised 31,281 restricted stock units @ $0
Exercised 32,794 restricted stock units @ $0
02/09/2023 4 Torley Helen (PRESIDENT AND CEO) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Sold 10,000 shares @ $51.258, valued at $512.6k
Sold 10,000 shares @ $51.357, valued at $513.6k
Sold 10,000 shares @ $50.4, valued at $504k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
Exercised 10,000 options to buy @ $14.66, valued at $146.6k
02/07/2023 4 Duncan Barbara Gayle (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.
Txns: Granted 1,188 shares @ $0
01/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy